{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:54:07Z","timestamp":1793843647612,"version":"4.6.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jneuroim.2020.577189","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T21:21:33Z","timestamp":1581628893000},"page":"577189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Immune-mediated epilepsy with GAD65 antibodies"],"prefix":"10.1016","volume":"341","author":[{"given":"Xinxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoshi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577189_bb0005","doi-asserted-by":"crossref","first-page":"102339","DOI":"10.1016\/j.jaut.2019.102339","article-title":"The immunobiology of autoimmune encephalitides","volume":"104","author":"Alexopoulos","year":"2019","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577189_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2011.05.005","article-title":"Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies","volume":"37","author":"Ali","year":"2011","journal-title":"J. Autoimmun."},{"issue":"2\u20133","key":"10.1016\/j.jneuroim.2020.577189_bb0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molimm.2009.08.022","article-title":"Structural determinants of GAD antigenicity","volume":"47","author":"Arafat","year":"2009","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.jneuroim.2020.577189_bb0020","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Arino","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jneuroim.2020.577189_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2019.04.007","article-title":"The neurological syndromes associated with glutamic acid decarboxylase antibodies","volume":"101","author":"Baizabal-Carvallo","year":"2019","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0030","first-page":"13","article-title":"Epilepsy and autoimmunity in pediatric patients","volume":"46","author":"Bektas","year":"2015","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0035","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejpn.2018.01.004","article-title":"Severe dysautonomia as a main feature of anti-GAD encephalitis: report of a paediatric case and literature review","volume":"22","author":"Ben Achour","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.yebeh.2007.03.011","article-title":"Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life","volume":"10","author":"Bien","year":"2007","journal-title":"Epilepsy Behav."},{"issue":"Pt 5","key":"10.1016\/j.jneuroim.2020.577189_bb0045","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577189_bb0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejpn.2016.03.005","article-title":"Autoantibodies to neuronal antigens in children with focal epilepsy and no prima facie signs of encephalitis","volume":"20","author":"Borusiak","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2020.577189_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0009-8981(03)00088-3","article-title":"A sensitive non-isotopic assay for GAD65 autoantibodies","volume":"331","author":"Brooking","year":"2003","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2007.11.077","article-title":"High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65\/GAD67 in stiff-person syndrome","volume":"366","author":"Burbelo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2018.05.004","article-title":"Efficacy of antiepileptic drugs in autoimmune epilepsy: a systematic review","volume":"59","author":"Cabezudo-Garcia","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.jneuroim.2020.577189_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.12.010","article-title":"Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies","volume":"129","author":"Carreno","year":"2017","journal-title":"Epilepsy Res."},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577189_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072921","article-title":"Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577189_bb0085","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jamaneurol.2013.3499","article-title":"Neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome","volume":"70","author":"Chang","year":"2013","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/cei.12026","article-title":"Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals","volume":"171","author":"Cheramy","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/1550059412459330","article-title":"Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody","volume":"44","author":"Cikrikcili","year":"2013","journal-title":"Clin EEG Neurosci"},{"key":"10.1016\/j.jneuroim.2020.577189_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","article-title":"Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy","volume":"80","author":"Daif","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.expneurol.2013.02.010","article-title":"Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome","volume":"247","author":"Dalakas","year":"2013","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0110","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1212\/WNL.57.5.780","article-title":"Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies","volume":"57","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577189_bb0115","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0120","doi-asserted-by":"crossref","first-page":"577063","DOI":"10.1016\/j.jneuroim.2019.577063","article-title":"Predictive value of high titer of GAD65 antibodies in a case of limbic encephalitis","volume":"337","author":"Di Giacomo","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577189_bb0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000207","article-title":"Immunoadsorption therapy in autoimmune encephalitides","volume":"3","author":"Dogan Onugoren","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1684\/epd.2018.0971","article-title":"GAD65 antibody-associated autoimmune epilepsy with unique independent bitemporal-onset ictal asystole","volume":"20","author":"D'Souza","year":"2018","journal-title":"Epileptic Disord"},{"issue":"10","key":"10.1016\/j.jneuroim.2020.577189_bb0135","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s00415-013-7110-0","article-title":"Anti-GAD antibody ocular flutter: expanding the spectrum of autoimmune ocular motor disorders","volume":"260","author":"Dubbioso","year":"2013","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0140","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1684\/epd.2014.0703","article-title":"Effectiveness of multimodality treatment for autoimmune limbic epilepsy","volume":"16","author":"Dubey","year":"2014","journal-title":"Epileptic Disord"},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2020.577189_bb0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.04.010","article-title":"Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients","volume":"211","author":"Errichiello","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.jneuroim.2020.577189_bb0160","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1468-1331.2011.03609.x","article-title":"Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies","volume":"19","author":"Falip","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0165","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fneur.2018.01143","article-title":"Hippocampus and insula are targets in epileptic patients with glutamic acid decarboxylase antibodies","volume":"9","author":"Falip","year":"2018","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577189_bb0170","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ane.12799","article-title":"Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies","volume":"137","author":"Falip","year":"2018","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jca.21342","article-title":"Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response","volume":"30","author":"Farooqi","year":"2015","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12883-015-0435-9","article-title":"Long latency between GAD-antibody detection and development of limbic encephalitis--a case report","volume":"15","author":"Fauser","year":"2015","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.autrev.2009.05.003","article-title":"Structural biology of the GAD autoantigen","volume":"9","author":"Fenalti","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaut.2008.04.013","article-title":"GAD65 as a prototypic autoantigen","volume":"31","author":"Fenalti","year":"2008","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nsmb1228","article-title":"GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop","volume":"14","author":"Fenalti","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0200","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000353","article-title":"Antiepileptic drug therapy in patients with autoimmune epilepsy","volume":"4","author":"Feyissa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1941875211413135","article-title":"Autoimmune limbic encephalitis with GAD antibodies","volume":"1","author":"Finelli","year":"2011","journal-title":"Neurohospitalist"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12311-014-0625-9","article-title":"Anti-GAD antibody, seizures, cerebellar ataxias and vitiligo: a diagnostic challenge","volume":"14","author":"Flores-Cantu","year":"2015","journal-title":"Cerebellum"},{"key":"10.1016\/j.jneuroim.2020.577189_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2015.03.009","article-title":"GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders","volume":"281","author":"Fouka","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00234-018-1976-6","article-title":"MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy","volume":"60","author":"Fredriksen","year":"2018","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0225","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1017\/cjn.2016.13","article-title":"Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature","volume":"43","author":"Gagnon","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.seizure.2016.02.006","article-title":"Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: a case report","volume":"37","author":"Gagnon","year":"2016","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.jneuroim.2020.577189_bb0235","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/pedi.12346","article-title":"Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies","volume":"17","author":"Ganelin-Cohen","year":"2016","journal-title":"Pediatr. Diabetes"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1684\/epd.2018.0993","article-title":"Refractory epilepsy secondary to anti-GAD encephalitis treated with DBS post SEEG evaluation: a novel case report based on stimulation findings","volume":"20","author":"Gillinder","year":"2018","journal-title":"Epileptic Disord"},{"issue":"9126","key":"10.1016\/j.jneuroim.2020.577189_bb0245","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(05)79192-3","article-title":"Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies","volume":"352","author":"Giometto","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0250","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121364","article-title":"Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity","volume":"10","author":"Gresa-Arribas","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jneuroim.2020.577189_bb0260","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1515\/jpem-2016-0016","article-title":"Type 1 diabetes and GAD65 limbic encephalitis: a case report of a 10-year-old girl","volume":"29","author":"Grilo","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0265","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fncel.2016.00130","article-title":"Anti-GAD65 containing cerebrospinal fluid does not Alter GABAergic transmission","volume":"10","author":"Hackert","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1750-1172-8-82","article-title":"Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats","volume":"8","author":"Hampe","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0275","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2016.10.016","article-title":"Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis","volume":"65","author":"Hansen","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yebeh.2017.10.033","article-title":"Pre- and long-term postoperative courses of hippocampus-associated memory impairment in epilepsy patients with antibody-associated limbic encephalitis and selective amygdalohippocampectomy","volume":"79","author":"Hansen","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0285","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000142","article-title":"Improvement of GAD65-associated autoimmune epilepsy with testosterone replacement therapy","volume":"2","author":"Heiry","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"17","key":"10.1016\/j.jneuroim.2020.577189_bb0290","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"issue":"27","key":"10.1016\/j.jneuroim.2020.577189_bb0295","doi-asserted-by":"crossref","first-page":"20822","DOI":"10.1074\/jbc.M001403200","article-title":"Association of L-glutamic acid decarboxylase to the 70-kDa heat shock protein as a potential anchoring mechanism to synaptic vesicles","volume":"275","author":"Hsu","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0300","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000502695","article-title":"Clinical heterogeneity in patients with glutamate decarboxylase antibody","volume":"26","author":"Huang","year":"2019","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0305","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","article-title":"Autoimmune Epilepsy","volume":"16","author":"Husari","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2020.577189_bb0310","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuro.2017.10.006","article-title":"Hypoxia regulates the level of glutamic acid decarboxylase enzymes and interrupts inhibitory synapse stability in primary cultured neurons","volume":"65","author":"Hwang","year":"2018","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0315","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13760-018-0880-5","article-title":"Autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: a case series","volume":"118","author":"Incecik","year":"2018","journal-title":"Acta Neurol. Belg."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2020.577189_bb0320","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jns.2008.04.019","article-title":"Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies","volume":"271","author":"Ishida","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0325","doi-asserted-by":"crossref","first-page":"577084","DOI":"10.1016\/j.jneuroim.2019.577084","article-title":"Multiple co-existing antibodies in autoimmune encephalitis: a case and review of the literature","volume":"337","author":"Kammeyer","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0330","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0972-2327.93267","article-title":"Paraneoplastic neurologic syndrome: a practical approach","volume":"15","author":"Kannoth","year":"2012","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0335","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1528-1167.2007.01500.x","article-title":"Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus","volume":"49","author":"Kanter","year":"2008","journal-title":"Epilepsia"},{"issue":"25","key":"10.1016\/j.jneuroim.2020.577189_bb0340","doi-asserted-by":"crossref","first-page":"E2524","DOI":"10.1073\/pnas.1403182111","article-title":"Cofactor-dependent conformational heterogeneity of GAD65 and its role in autoimmunity and neurotransmitter homeostasis","volume":"111","author":"Kass","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0345","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1684\/epd.2014.0666","article-title":"PET-positive extralimbic presentation of anti-glutamic acid decarboxylase antibody-associated encephalitis","volume":"16","author":"Kojima","year":"2014","journal-title":"Epileptic Disord"},{"issue":"8","key":"10.1016\/j.jneuroim.2020.577189_bb0350","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archneurol.2011.177","article-title":"Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?","volume":"68","author":"Korff","year":"2011","journal-title":"Arch. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2020.577189_bb0355","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jns.2013.08.016","article-title":"Histopathological evidence that hippocampal atrophy following status epilepticus is a result of neuronal necrosis","volume":"334","author":"Kumar","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.jneuroim.2020.577189_bb0360","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-1211(00)00180-7","article-title":"Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study","volume":"42","author":"Kwan","year":"2000","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0365","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/cercor\/bht322","article-title":"GAD67 deficiency in parvalbumin interneurons produces deficits in inhibitory transmission and network disinhibition in mouse prefrontal cortex","volume":"25","author":"Lazarus","year":"2015","journal-title":"Cereb. Cortex"},{"issue":"12","key":"10.1016\/j.jneuroim.2020.577189_bb0370","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12272-019-01196-z","article-title":"The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0375","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2020.577189_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.08.001","article-title":"Immunological perspectives of temporal lobe seizures","volume":"263","author":"Liimatainen","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0385","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13023-018-0787-5","article-title":"GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies","volume":"13","author":"Liimatainen","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"8","key":"10.1016\/j.jneuroim.2020.577189_bb0390","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.seizure.2014.04.009","article-title":"Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications","volume":"23","author":"Lilleker","year":"2014","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0395","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pediatrneurol.2012.06.013","article-title":"Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus","volume":"47","author":"Lin","year":"2012","journal-title":"Pediatr. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577189_bb0400","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000490530","article-title":"Glutamic acid decarboxylase antibody in a patient with myelitis: a retrospective study","volume":"25","author":"Liu","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2020.577189_bb0405","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fneur.2018.00579","article-title":"Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs","volume":"9","author":"Makela","year":"2018","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0410","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0415","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","article-title":"Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies","volume":"30","author":"Malter","year":"2015","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.jneuroim.2020.577189_bb0420","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.21123","article-title":"Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases","volume":"61","author":"Manto","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-6-3","article-title":"Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia","volume":"6","author":"Manto","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0430","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnbeh.2015.00078","article-title":"Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions","volume":"9","author":"Manto","year":"2015","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577189_bb0435","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12311-018-0986-6","article-title":"Anti-GAD antibodies and the cerebellum: where do we stand?","volume":"18","author":"Manto","year":"2019","journal-title":"Cerebellum"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0440","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.transci.2008.09.005","article-title":"Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis","volume":"39","author":"Mazzi","year":"2008","journal-title":"Transfus. Apher. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.jneuroim.2020.577189_bb0450","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","article-title":"Serum antibodies in epilepsy and seizure-associated disorders","volume":"65","author":"McKnight","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0455","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jnnp.71.1.100","article-title":"Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases","volume":"71","author":"Meinck","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"49","key":"10.1016\/j.jneuroim.2020.577189_bb0460","doi-asserted-by":"crossref","first-page":"15397","DOI":"10.1523\/JNEUROSCI.4339-09.2009","article-title":"Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death","volume":"29","author":"Meuth","year":"2009","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577189_bb0465","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13760-014-0332-9","article-title":"Idiopathic limbic encephalitis associated with antibodies to glutamic acid decarboxylase","volume":"115","author":"Millet","year":"2015","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0470","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/gbb.12188","article-title":"The GAD65 knock out mouse - a model for GABAergic processes in fear- and stress-induced psychopathology","volume":"14","author":"Muller","year":"2015","journal-title":"Genes Brain Behav."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0475","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.yebeh.2011.03.038","article-title":"Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: an underdiagnosed entity?","volume":"21","author":"Najjar","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0480","doi-asserted-by":"crossref","first-page":"577025","DOI":"10.1016\/j.jneuroim.2019.577025","article-title":"Can serum GAD65 antibody levels predict neurological disease or cancer?","volume":"336","author":"Olberg","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0485","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0490","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000592","article-title":"Novel clinical features of glycine receptor antibody syndrome: a series of 17 cases","volume":"6","author":"Piquet","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0495","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577189_bb0500","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/81.9.1207","article-title":"Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction","volume":"81","author":"Pittock","year":"2006","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191794","article-title":"Enhanced susceptibility to stress and seizures in GAD65 deficient mice","volume":"13","author":"Qi","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0510","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2020.577189_bb0515","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-010-5476-9","article-title":"Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil","volume":"257","author":"Saidha","year":"2010","journal-title":"J. Neurol."},{"issue":"Pt 10","key":"10.1016\/j.jneuroim.2020.577189_bb0520","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jneuroim.2020.577189_bb0525","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1212\/CPJ.0000000000000148","article-title":"Anti-GAD antibody syndrome with concomitant cerebellar ataxia, stiff person syndrome, and limbic encephalitis","volume":"5","author":"Schaefer","year":"2015","journal-title":"Neurol Clin. Pract."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0530","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2016.04.046","article-title":"Paraneoplastic epilepsy","volume":"61","author":"Serafini","year":"2016","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0535","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WCO.0000000000000449","article-title":"Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis","volume":"30","author":"Spatola","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577189_bb0540","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1528-1167.2010.02644.x","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels","volume":"51","author":"Stagg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2020.577189_bb0545","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fneur.2015.00189","article-title":"Serum from a patient with GAD65 antibody-associated limbic encephalitis did not Alter GABAergic neurotransmission in cultured hippocampal networks","volume":"6","author":"Stemmler","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0550","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2377-11-156","article-title":"Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report","volume":"11","author":"Takagi","year":"2011","journal-title":"BMC Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2020.577189_bb0555","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.braindev.2018.06.002","article-title":"Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause","volume":"40","author":"Tekturk","year":"2018","journal-title":"Brain Dev."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0560","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2018.06.013","article-title":"Fulminant anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression","volume":"323","author":"Triplett","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.jneuroim.2020.577189_bb0565","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/cercor\/bht060","article-title":"The GABAergic septohippocampal pathway is directly involved in internal processes related to operant reward learning","volume":"24","author":"Vega-Flores","year":"2014","journal-title":"Cereb. Cortex"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2020.577189_bb0570","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eplepsyres.2013.02.009","article-title":"Newly-diagnosed pediatric epilepsy is associated with elevated autoantibodies to glutamic acid decarboxylase but not cardiolipin","volume":"105","author":"Veri","year":"2013","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0575","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1468-1331.2004.00933.x","article-title":"Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies","volume":"12","author":"Vianello","year":"2005","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577189_bb0580","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.expneurol.2006.06.012","article-title":"Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-ab)","volume":"202","author":"Vianello","year":"2006","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577189_bb0585","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/08916930701619565","article-title":"Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies","volume":"41","author":"Vianello","year":"2008","journal-title":"Autoimmunity"},{"issue":"7","key":"10.1016\/j.jneuroim.2020.577189_bb0590","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/jnnp-2014-307875","article-title":"Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis","volume":"86","author":"Wagner","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577189_bb0595","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/epi.12968","article-title":"Early and chronic gray matter volume changes in limbic encephalitis revealed by voxel-based morphometry","volume":"56","author":"Wagner","year":"2015","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577189_bb0600","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.13297","article-title":"Distinct white matter integrity in glutamic acid decarboxylase and voltage-gated potassium channel-complex antibody-associated limbic encephalitis","volume":"57","author":"Wagner","year":"2016","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.jneuroim.2020.577189_bb0605","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4065\/73.12.1161","article-title":"Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus","volume":"73","author":"Walikonis","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0610","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fneur.2015.00167","article-title":"Treating a GAD65 antibody-associated limbic encephalitis with Basiliximab: a case study","volume":"6","author":"Widman","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577189_bb0615","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fneur.2015.00130","article-title":"Loss of autonoetic awareness of recent autobiographical episodes and accelerated long-term forgetting in a patient with previously unrecognized glutamic acid decarboxylase antibody related limbic encephalitis","volume":"6","author":"Witt","year":"2015","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577189_bb0620","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1759-7714.13009","article-title":"Paraneoplastic autoimmunity and small-cell lung cancer: neurological and serological accompaniments","volume":"10","author":"Zekeridou","year":"2019","journal-title":"Thorac Cancer"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820300278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820300278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:36:28Z","timestamp":1759048588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820300278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":124,"alternative-id":["S0165572820300278"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577189","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated epilepsy with GAD65 antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577189"}}